Clinical Trial: A Study of Patients' Preferences for Primary Immune Thrombocytopenia Treatment

U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07786077) titled 'A Study of Patients' Preferences for Primary Immune Thrombocytopenia Treatment' on Aug. 21.

Brief Summary: This study aims to evaluate treatment preferences of patients with Primary Immune Thrombocytopenia (ITP) in the United States (US) by conducting a preference elicitation survey.

Study Start Date: Dec. 08, 2025

Study Type: OBSERVATIONAL

Condition: Primary Immune Thrombocytopenia

Recruitment Status: RECRUITING

Sponsor: Novartis Pharmaceuticals

Published by HT Digital Content Services with permission from Health Daily Digest....